Background Few data are available regarding the efficacy and safety of a single-pill
combination (SPC) consisting of four medications in patients with concomitant hypertension …

Purpose The objective of this study was to evaluate the efficacy and tolerability of a triple
combination of amlodipine/losartan/rosuvastatin in patients with hypertension and …

Background: This study was a multicenter, randomized, double-blinded, placebo-controlled
phase III clinical trial to investigate the efficacy and safety of an olmesartan/amlodipine …

Introduction This study evaluated the efficacy and safety of a single-pill triple-combination of
olmesartan/amlodipine/rosuvastatin (Olme/Amlo/Rosu) in comparison with a single-pill dual …

This multicenter, randomized, double‐blind, parallel‐group phase III clinical trial aimed to
investigate the efficacy and safety of a rosuvastatin+ amlodipine combination compared with …

The Gemini Study was a 14‐week, open‐label, noncomparative, office‐based, multicenter
trial to evaluate single‐pill therapy in the treatment of concomitant hypertension and …

Background Hypertension and hypercholesterolemia are important risk factors for
cardiovascular disease, and treatment with fixed‐dose combination (FDC) regimens is …

This study aimed to compare and evaluate the efficacy of the blood pressure (BP) control
and cholesterol‐lowering effects and safety of combination therapy with telmisartan …

Hypertension and dyslipidemia are important risk factors for cardiovascular disease.
However, the clinical outcomes of fixed‐dose combination (FDC) versus free‐equivalent …

Background Blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) are
important risk factors for cardiovascular (CV) diseases. Although treating these factors …